OPKO Health Corp. (OPK) - Rasio utang jangka dawa marang modal

OPKO Health, Inc. (OPK) is developing a comprehensive medical service that combines pharmaceutical production with the BioReference diagnostic network. This chart from GURU.Markets shows the share price at 0.30, confirming the asset's market valuation. The company integrates treatment and testing for full patient management, although the stable B2B segment is currently suffering from declining Medicare reimbursement rates, which is negatively impacting profitability.

OPKO Health, Inc. (OPK) revenues from genetic testing and nephrology drugs establish the foundation for long-term R&D investment. The ratio of liabilities with a maturity of over one year to total capital determines the degree of financial autonomy, where reduced reliance on borrowed funds confirms the stability of the balance sheet structure, clearly reflecting the level of long-term loans relative to equity.